1. Home
  2. UPB vs CPAC Comparison

UPB vs CPAC Comparison

Compare UPB & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPB
  • CPAC
  • Stock Information
  • Founded
  • UPB 2021
  • CPAC 1949
  • Country
  • UPB United States
  • CPAC Peru
  • Employees
  • UPB N/A
  • CPAC N/A
  • Industry
  • UPB
  • CPAC Building Materials
  • Sector
  • UPB
  • CPAC Industrials
  • Exchange
  • UPB NYSE
  • CPAC Nasdaq
  • Market Cap
  • UPB 457.2M
  • CPAC 475.3M
  • IPO Year
  • UPB 2024
  • CPAC 2012
  • Fundamental
  • Price
  • UPB $7.98
  • CPAC $5.77
  • Analyst Decision
  • UPB Strong Buy
  • CPAC Sell
  • Analyst Count
  • UPB 4
  • CPAC 1
  • Target Price
  • UPB $56.50
  • CPAC $6.00
  • AVG Volume (30 Days)
  • UPB 245.5K
  • CPAC 5.1K
  • Earning Date
  • UPB 03-04-2025
  • CPAC 03-04-2025
  • Dividend Yield
  • UPB N/A
  • CPAC 8.69%
  • EPS Growth
  • UPB N/A
  • CPAC 17.75
  • EPS
  • UPB N/A
  • CPAC 0.12
  • Revenue
  • UPB $2,207,000.00
  • CPAC $524,464,683.00
  • Revenue This Year
  • UPB N/A
  • CPAC N/A
  • Revenue Next Year
  • UPB N/A
  • CPAC N/A
  • P/E Ratio
  • UPB N/A
  • CPAC $9.19
  • Revenue Growth
  • UPB 82.10
  • CPAC 1.44
  • 52 Week Low
  • UPB $6.65
  • CPAC $5.10
  • 52 Week High
  • UPB $29.46
  • CPAC $6.65
  • Technical
  • Relative Strength Index (RSI)
  • UPB N/A
  • CPAC 49.77
  • Support Level
  • UPB N/A
  • CPAC $5.70
  • Resistance Level
  • UPB N/A
  • CPAC $6.00
  • Average True Range (ATR)
  • UPB 0.00
  • CPAC 0.15
  • MACD
  • UPB 0.00
  • CPAC -0.01
  • Stochastic Oscillator
  • UPB 0.00
  • CPAC 31.88

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: